gebhart/patrepeval huggingface dataset:
Trademark Trial and Appeal Board (2018)

The Trademark Trial and Appeal Board (TTAB) hears and decides adversary proceedings involving: oppositions to the registration of trademarks, petitions to cancel trademark registrations and proceedings involving applications for concurrent use registrations of trademarks. The Board also decides appeals taken from the trademark examining attorneys' refusals to allow registration of trademarks. The TTAB Assistance Center is available for telephone and email inquiries Monday-Friday 8:30 a.m.-5:00 p.m. ET (except federal holidays).
Serpin-Protease Complexes Are Trapped as Stable Acyl-Enzyme Intermediates (1995)

The serine protease inhibitors of the serpin family are an unusual group of proteins thought to have metastable native structures. Functionally, they are unique among polypeptide protease inhibitors, although their precise mechanism of action remains controversial. Conflicting results from previous studies have suggested that the stable serpin-protease complex is trapped in either a tight Michaelis-like structure, a tetrahedral intermediate, or an acyl-enzyme. In this report we show that, upon association with a target protease, the serpin reactive-center loop (RCL) is cleaved resulting in formation of an acyl-enzyme intermediate. This cleavage is coupled to rapid movement of the RCL into the body of the protein bringing the inhibitor closer to its lowest free energy state. From these data we suggest a model for serpin action in which the drive toward the lowest free energy state results in trapping of the protease-inhibitor complex as an acyl-enzyme intermediate.
Electrochromic properties of a fast switching, dual colour polythiophene bearing non-planar dithiinoquinoxaline units (2006)

The synthesis and electropolymerisation of a new terthiophene, 1,3-di-2-thienylthieno[3′,4′:5,6][1,4]dithiino[2,3-b]quinoxaline, is reported. The compound bears a quinoxaline unit fused to the central thiophene ring via a 1,4-dithiin ring; the latter unit ensures a non-planar structure for the molecule. The corresponding polymer, prepared electrochemically, has been characterized by cyclic voltammetry and UV-vis-NIR spectroelectrochemistry. The material is oxidised within the conjugated chain, but the reduction processes are complex and arise from both the polythiophene and the independent quinoxaline units. The polymer has two distinct colour states—orange in the neutral form and green–blue in the oxidised state. Electrochromic studies on poly(1,3-di-2-thienylthieno[3′,4′:5,6][1,4]dithiino[2,3-b]quinoxaline) reveal fast switching speeds that are superior to those of poly(3,4-ethylenedioxythiophene) (PEDOT) and a colouration efficiency of 381 cm2 C−1 at 650 nm.
DNA and Actin Bind and Inhibit Interleukin-8 Function in Cystic Fibrosis Sputa (2000)

Infection of the cystic fibrosis (CF) airways elicits an exaggerated, interleukin-8 (IL-8) mediated, neutrophil inflammatory response. Necrosing neutrophils release DNA and actin into the airways, increasing the viscoelasticity of airway secretions. Mucolytics aim to improve airway clearance by reducing this viscoelasticity. DNase I reduces the viscoelasticity of CF sputum, and a human recombinant form of this enzyme is widely administered to patients with CF. Gelsolin, which cleaves actin polymers, is also known to reduce CF sputum viscosity in vitro, and it has been proposed as a future mucolytic agent. We have shown that the anionic polymers DNA and actin bind and mask immunologic recognition of the basic peptide IL-8 and prevent this chemokine from binding to neutrophil receptors. Reduction of CF sputum viscosity by DNase I or gelsolin in vitro was demonstrated to increase the proportion of free IL-8 and the IL-8-dependent neutrophil chemotactic activity of sputum supernatants. We hypothesize that an electrostatic interaction between polymer and chemokine may limit the inflammatory potential of the latter, but that this interaction may be weakened by polymer cleavage. The potential risk of increased inflammation via this mechanism suggests a caveat should be attendant on treatment of patients with CF with these mucolytic agents.
Gas/Solid Reactions with Nitrogen Dioxide (1995)

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTGas/Solid Reactions with Nitrogen DioxideGerd Kaupp and Jens SchmeyersCite this: J. Org. Chem. 1995, 60, 17, 5494–5503Publication Date (Print):September 1, 1995Publication History Published online1 May 2002Published inissue 1 September 1995https://pubs.acs.org/doi/10.1021/jo00122a031https://doi.org/10.1021/jo00122a031research-articleACS PublicationsRequest reuse permissionsArticle Views1296Altmetric-Citations54LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies (2003)

MLL amplification was recently recognized as a recurrent aberration in acute myeloid leukemia (AML) and myelodys-plastic syndrome (MDS), associated with adverse prognosis and karyotype complexity. Here we present detailed results of fluorescence in situ hybridization (FISH) and expression analyses of MLL and 5 selected 11q candidate oncogenes (CBL, DDX6, ETS1, FLI1, and PLZF) in 31 patient samples and one cell line with 11q23 gain. FISH analyses revealed that the 11q23 amplicon invariably encompassed MLL, DDX6, ETS1, and FLI1, whereas expression analyses identified MLL and DDX6 as the most differentially expressed genes among samples with and without 11q23 copy gain or amplification. In MLL-amplified samples, a significant transcriptional up-regulation of MEIS1, PROML1, ADAM10, NKG2D, and ITPA was noted. Further analyses, designed to elucidate a possible role of the 11q overexpressed genes (MLL, DDX6, FLI1, and ETS1) in unselected MDS and AML samples, revealed a significant upregulation of MLL in MDS. Our findings confirm the MLL gene as a prominent target of 11q23 amplification and provide further evidence for an etiologic role for MLL gain of function in myeloid malignancies. In addition, our results indicate that the transcriptional program associated with MLL rearrangements and MLL overexpression displays significant similarities.
Mutational Analysis of PC1 (SPC3) in PC12 Cells (1995)

The proteinase mPC1, a neuroendocrine member of the mammalian family of subtilisin-like enzymes, has previously been shown to be converted to a carboxyl-terminally truncated 66-kDa form during transport through the secretory pathway. The cleavage site and the function of this carboxyl-terminal truncation event are unknown. We have performed site-directed mutagenesis of two paried basic sites in the mPC1 carboxyl-terminal tail and expressed these constructs in PC12 cells, a rat pheochromocytoma known to lack endogenous PC1. We found that the most likely site for the truncation event was at Arg590-Arg591 since mutation of this site to Lys-His prevented processing of 87-kDa PC1. A PC1 mutant carboxyl-terminally truncated at this site and expressed in PC12 cells was efficiently routed to the secretory pathway and stored in secretory granules, indicating that the carboxyl-terminal extension is not required for sorting of this enzyme. The function of the various PC1 constructs was assessed by analyzing proneurotensin cleavage to various forms. The carboxyl-terminally truncated PC1 mutant was found to perform most of the cleavages of this precursor as well as wild-type PC1; however, the blockade mutant processed proneurotensin much less efficiently. Differences between the site preferences of the various enzymes were noted. Our results support the notion that carboxyl-terminal processing of PC1 serves to regulate PC1 activity.
Efficient Metal-Free Oxygen Reduction in Alkaline Medium on High-Surface-Area Mesoporous Nitrogen-Doped Carbons Made from Ionic Liquids and Nucleobases (2010)

Mesoporous nitrogen-doped carbon materials with high surface areas up to 1500 m(2) g(-1) were conveniently made by the carbonization of nucleobases dissolved in an all-organic ionic liquid (1-ethyl-3-methylimidazolium dicyanamide). Using hard templating with silica nanoparticles, this process yields high-surface-area nitrogen-doped carbon materials with nitrogen contents as high as 12 wt %, narrow mesopore size distribution of ca. 12 nm diameter, and local graphitic carbon structure. It is demonstrated that the resulting nitrogen-doped carbons show very high catalytic activity, even in the metal-free case in the oxygen reduction reaction (ORR) for fuel cells. Specifically, the as-prepared materials exhibit a low onset voltage for ORR in alkaline medium and a high methanol tolerance, compared with those of commercial 20 wt % Pt/C catalyst. We regard this as a first step toward an all-sustainable fuel cell, avoiding noble metals.
A Means for Expressing Location Information in the Domain Name System (1996)

This memo defines a new DNS RR type for experimental purposes. This RFC describes a mechanism to allow the DNS to carry location information about hosts, networks, and subnets. Such information for a small subset of hosts is currently contained in the flat-file UUCP maps. However, just as the DNS replaced the use of HOSTS.TXT to carry host and network address information, it is possible to replace the UUCP maps as carriers of location information.
Location in distributed ad-hoc wireless sensor networks (2002)

Evolving networks of ad-hoc wireless sensing nodes rely heavily on the ability to establish position information. The algorithms presented herein rely on range measurements between pairs of nodes and the a priori coordinates of sparsely located anchor nodes. Clusters of nodes surrounding anchor nodes cooperatively establish confident position estimates through assumptions, checks, and iterative refinements. Once established, these positions are propagated to more distant nodes, allowing the entire network to create an accurate map of itself. Major obstacles include overcoming inaccuracies in range measurements as great as /spl plusmn/50%, as well as the development of initial guesses for node locations in clusters with few or no anchor nodes. Solutions to these problems are presented and discussed, using position error as the primary metric. Algorithms are compared according to position error, scalability, and communication and computational requirements. Early simulations yield average position errors of 5% in the presence of both range and initial position inaccuracies.
Inhibition of Acetylcholinesterase, β-Amyloid Aggregation, and NMDA Receptors in Alzheimer’s Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush (2008)

Alzheimer's disease (AD) is a multifactorial syndrome with several target proteins contributing to its etiology. To confront AD, an innovative strategy is to design single chemical entities able to simultaneously modulate more than one target. Here, we present compounds that inhibit acetylcholinesterase and NMDA receptor activity. Furthermore, these compounds inhibit AChE-induced Abeta aggregation and display antioxidant properties, emerging as lead candidates for treating AD.
Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2 (1995)

The immunotherapeutic potential of three anti-rat CD2 monoclonal antibodies (mAb) (OX34, OX54, OX55) and the combination of OX54 with OX55 was tested in Lewis rat experimental autoimmune encephalomyelitis (EAE). In actively induced EAE, a single injection of OX34 2 days before immunization with myelin basic protein (MBP) in complete Freund's adjuvant (CFA) completely prevented or greatly attenuated EAE in all animals. Injection of OX54 acted moderately suppressive while OX55 or OX54/55 did not affect disease severity. Abrogation of EAE by OX34 was not restricted to its application before immunization. Therapeutic administration of all three mAb and the Ab combination from onset of first clinical signs efficiently blocked progression of disease and prevented all animals from developing hind limb paresis. In adoptive transfer EAE induced with in vitro activated cells of an encephalitogenic T helper line, clinical and histological signs were completely prevented by injection of OX34 on the day of cell transfer and 4 days later, underlining the strong impact of anti-CD2 mAb on the effector phase of disease. Immunocytofluorometric analysis of peripheral blood lymphocytes after a single Ab injection demonstrated that all mAb induced a variable degree of transient reduction in T cell numbers and modulation of CD2 antigens. In contrast to the other mAb, OX34 persisted on lymphocytes for at least 11 days, which may explain its unique suppressive effect on EAE after a single injection before immunization. The assumption that prophylactic administration of OX34 also inhibits MBP-induced EAE, due to persistence into the effector phase, was substantiated by the finding that none of the mAb prevented generation of an antigen-specific cellular response in MBP/CFA-immunized animals. Since none of the Ab induced T cell unresponsiveness or inhibited T cell activation by antigen- or Ab-mediated stimulation of the T cell receptor, we suggest that their marked action on the effector phase of EAE may rely on inhibition of T cell infiltration into the central nervous system. The demonstrated efficacy of these anti-CD2 mAb in EAE suggests a potential therapeutic role that may be equal to that of anti-CD4 or anti-T cell receptor Ab.
Behavior, sleep and melatonin. (1986)

The focus of most behavioral studies on melatonin relate to sleep, arousal levels and circadian rhythms of alertness. It has also been suggested that melatonin administration can reduce anxiety (Golus and King, 1981), affect learning (Datta and King, 1980), and exacerbate symptoms in patients suffering from severe depression (Carman et al., 1976). For a variety of reasons the effects of exogenous melatonin on sleep and circadian rhythms seem most likely to reflect the actual physiological functions of the endogenous hormone; however, definitive relationships between melatonin secretion and these effects have not yet been established. Administration of melatonin to humans in pharmacologic doses produces acute hypnotic-like effects (Vollrath et al., 1981; Lieberman et al., 1984). Available evidence suggests that melatonin may participate in the physiological regulation of sleep, particularly in determining the phase of circadian rhythms of sleep and sleepiness (Redman et al., 1983; Wurtman and Lieberman, 1985).
Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features (1990)

Structural and immunological differences between the two components that are usually present in unequal quantities in Bordetella pertussis endotoxin preparations and are visualized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis have been studied by using strains 1414, A100, and 134, all in phase I. According to analyses by both sodium dodecyl sulfate-polyacrylamide gel electrophoresis and thin-layer chromatography, the minor (8%) component of the endotoxin of strain 1414 (endotoxin 1414) appeared to be the predominating component of endotoxins A100 and 134. The masses of the carbohydrate chains isolated from endotoxin A100 and from the major component of endotoxin 1414 were 1,649 and 2,311 atomic mass units, respectively, as determined by 252Cf plasma desorption mass spectrometry. Comparison of the 1H nuclear magnetic resonance spectra of these chains established that four N-acetyl groups, an N-methyl group, and a 6-deoxy function, which characterize the nonreducing, distal trisaccharide of the glycose chain of strain 1414, were absent from that of strain A100. The antigenicity of endotoxin 1414, as measured by enzyme-linked immunosorbent assay, was higher than that of endotoxin A100, but fell below it when the glycose chain of endotoxin 1414 was deprived of seven sugars by treatment with nitrous acid. This observation suggests that at least three (distal, proximal, and intermediate) regions of the glycose chain of endotoxin 1414 carry antigenic determinants. One of these, located in the distal trisaccharide, is absent from both endotoxins A100 and 134.
GP remuneration compared with non-health care costs (2010)

are a major tool to reduce morbidity. 5,6 South Africa is a signatory of World Health Assembly Resolution 54.19 that calls on member states to take effective steps to control schistosomiasis and soiltransmitted helminthiasis. This calls for non-selective treatment of all children at risk, and targets the year 2010 for regular chemotherapy programmes. 6 The importance of such preventive policies is because praziquantel kills the adult schistosoma but not the ova. The ova cause granulomas, the entry and exit for the transmission of HIV, and possibly act as a co-factor in cervical carcinogenesis.
Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis. (1994)

To investigate the involvement of protein tyrosine kinases (PTKs) in the growth control of mammary epithelial cells, we have used PCR based cloning to identify PTKs expressed in a mouse mammary epithelial cell line. This approach led to the isolation of two receptor PTKs of the eph-related subfamily; myk-1, a novel member expressed predominantly in lung, heart and mammary gland and myk-2, a close relative of the human eck gene. Northern blot analysis of RNA from mouse mammary glands at different stages of development revealed that myk-1 and myk-2 expression is induced at puberty and differentially regulated during the estrus cycle. myk-1 and myk-2 expression was down-regulated during the pregnancy induced differentiation of the mammary gland. Over-expression of myk-1 and myk-2 was found in the undifferentiated and invasive mammary tumors of transgenic mice expressing the Ha-ras oncogene. In contrast, no elevated expression of either gene could be detected in the well differentiated and non-metastatic mammary tumors of c-myc expressing transgenic mice. These results indicate that myk-1 and myk-2 expression is induced during the proliferation of the mammary gland and down-regulated by its differentiation.
Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III (2006)

Overexpression of the epidermal growth factor (EGF) receptor occurs frequently in ovarian cancer and is associated with poor patient prognosis. A constitutively active mutant EGF receptor termed variant III (EGFRvIII) has been detected at a high frequency in many human tumors, including those of the ovary. To identify the consequences of EGFRvIII expression in ovarian tumor cells, we introduced EGFRvIII into the epithelial ovarian cancer cell line (OVCA 433). The EGFRvIII-transfected cells displayed a dissociated, motile phenotype and fibroblastic morphology. The EGFRvIII-dependent phenotype was comparable to that observed in EGF-stimulated parental OVCA 433 cultures and required the catalytic activity of the mutant receptor. Disruption of adherens and desmosomal junctions in EGFRvIII expressing cells was evident by immunofluorescent detection of specific junctional components. In addition, Western blot analysis confirmed decreased levels of cellular plakoglobin and beta-catenin in EGFRvIII-expressing cells, and E-cadherin protein and mRNA were nearly absent. The loss of E-cadherin was accompanied by decreased expression of additional ovarian epithelial markers, including keratins 7, 8, and 18 and mucins 1 and 4. In contrast, the mesenchymal markers N-cadherin and vimentin were elevated in EGFRvIII expressing cells. Overall, the switch in cadherins from E-cadherin to N-cadherin, coupled with gain of vimentin expression and loss of the epithelial keratins and mucins typically expressed in well-differentiated epithelial ovarian carcinomas, are consistent with transition to a mesenchymal phenotype as an outcome of EGFRvIII expression. These findings suggest that EGFRvIII expression may regulate phenotypic plasticity in ovarian cancer and thereby contribute to more aggressive disease.
Infiltration of a 3-D Fabric for the Production of SiC/SiC Composites by Means of Electrophoretic Deposition (2009)

Electrophoretic deposition (EPD) was used to infiltrate 2D and 3D SiC fabrics with SiC submicron particles with the aim to verify the potential of the technique for the fabrication of dense SiC/SiC composites. Bulk SiC deposits were first prepared from aqueous suspensions with different dispersants using cathodic and anodic deposition. The most suitable composition of the suspensions and the conditions for the infiltration were determined on the basis of the analysis of green parts formed. Using a specially designed EPD cell a relatively high packing density of SiC particles in infiltrated 2D and 3D SiC-fiber fabrics was achieved.
Interleukin-19 blockade attenuates collagen-induced arthritis in rats (2011)

Specifically blocking IL-19 inhibited pro-inflammatory cytokine production and prevented bone destruction in CIA rats. These findings provide evidence that IL-19 is a novel target, and that anti-IL-19 antibody may be a potential target to ameliorate the severity of RA.
Universal phosphatase-coupled glycosyltransferase assay (2010)

A nonradioactive glycosyltransferase assay is described here. This method takes advantage of specific phosphatases that can be added into glycosyltransferase reactions to quantitatively release inorganic phosphate from the leaving groups of glycosyltransferase reactions. The released phosphate group is then detected using colorimetric malachite-based reagents. Because the amount of phosphate released is directly proportional to the sugar molecule transferred in a glycosyltransferase reaction, this method can be used to obtain accurate kinetic parameters of the glycosyltransferase. The assay can be performed in multiwell plates and quantitated by a plate reader, thus making it amenable to high-throughput screening. It has been successfully applied to all glycosyltransferases available to us, including glucosyltransferases, N-acetylglucosaminyltransferases, N-acetylgalactosyltransferases, galactosyltransferases, fucosyltransferases and sialyltransferases. As examples, we first assayed Clostridium difficile toxin B, a protein O-glucosyltransferase that specifically monoglucosylates and inactivates Rho family small GTPases; we then showed that human KTELC1, a homolog of Rumi from Drosophila, was able to hydrolyze UDP-Glc; and finally, we measured the kinetic parameters of human sialyltransferase ST6GAL1.